Popular on s4story
- People & Stories/Gente y Cuentos Announces New Board Leadership & Corporate Partnership Initiative - 127
- Mensa identifies best board games of 2025 - 124
- Electives Appoints DraftKings' CPO Linda Aiello to Board Amid Record Quarter
- Is Billboard Advertising Still Effective in 2025?
- Two exciting new fantasy & adventure books are published
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet
- "The Eyes Have It" a Short Story by Philip K. Dick Now Available on Audiobook
- Fairfield Inn by Marriott Scottsdale Old Town Opens
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
Similar on s4story
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- Events by Dubsdread Expands Services to The Venue at Lake Lily
- Garden State Gay Socials Turns One: 1st Birthday Celebration for Gay Men Who Want Real Connection
- Global Families Turn to Young Travelers Concierge Amid Rising Safety Concerns in the U.S
2023 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Best Practices for Successful Outcomes in Patients with Heart Failure
S For Story/10600110
This CME Symposium takes place during the 2023 HFSA Annual Scientific Meeting of the Heart Failure Society of America #HFSA2023 on Sunday, October 8, 2023 from 5:00 PM - 6:00 PM EDT at the Huntington Convention Center, Cleveland, Ohio.
HAZLET, N.J. - s4story -- In this program, experts in cardiac amyloidosis will discuss best practices for identifying HF patients for screening for ATTR-CM, explain screening and diagnostic approaches, and describe current and emerging treatments for ATTR-CM.
Click here for more information
CHAIR
Mathew Maurer, MD
Professor of Medicine
Columbia University Medical Center
New York, New York
FACULTY
Ahmad Masri, MD, MS
Assistant Professor of Medicine
Oregon Health & Science University
Portland, Oregon
Brett Sperry, MD
Associate Professor of Medicine
University of Missouri-Kansas City
Kansas City, Missouri
This educational activity is intended for clinicians treating patients with heart failure.
More on S For Story
Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.
Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is approved for continuing nursing education (CNE) units by the HFSA, an accredited provider of the American Nurses Credentialing Center. This activity is approved for a maximum of 1.0 contact hours. Learners should claim only the credit commensurate with the extent of their participation in the activity.
The Heart Failure Society of America is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This activity is accredited for 1.0 contact hours of knowledge-based CPE under the ACPE universal activity number JA4008267-0000-21-003-L04-P.
Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #HFSA2023 #ATTRCM #heartfailure #heart
Click here for more information
CHAIR
Mathew Maurer, MD
Professor of Medicine
Columbia University Medical Center
New York, New York
FACULTY
Ahmad Masri, MD, MS
Assistant Professor of Medicine
Oregon Health & Science University
Portland, Oregon
Brett Sperry, MD
Associate Professor of Medicine
University of Missouri-Kansas City
Kansas City, Missouri
This educational activity is intended for clinicians treating patients with heart failure.
More on S For Story
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.
Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is approved for continuing nursing education (CNE) units by the HFSA, an accredited provider of the American Nurses Credentialing Center. This activity is approved for a maximum of 1.0 contact hours. Learners should claim only the credit commensurate with the extent of their participation in the activity.
The Heart Failure Society of America is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This activity is accredited for 1.0 contact hours of knowledge-based CPE under the ACPE universal activity number JA4008267-0000-21-003-L04-P.
Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #HFSA2023 #ATTRCM #heartfailure #heart
Source: CMEPlanet
Filed Under: Education
0 Comments
Latest on S For Story
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Sci-Fi Author Christian Hurst on Creativity, Resilience, and Making Art Anyway
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Arlina A.'s A LETTER TO PAWTONE Explores Childhood Innocence and the Moments That Shape Us
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban